Sections

Alphabetical list:

A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9

News: November 5, 2009

To Quit Smoking, Use Patch Plus Lozenge

November 5, 2009

Out of five different smoking cessation methods, the nicotine patch plus lozenges proved to be the most effective, according to research published in the November issue of Archives of General Psychiatry. The study is the first to compare the different products against each other.

Megan E. Piper, PhD and colleagues at the University of Wisconsin School of Medicine and Public Health found this combination to be the only modality with significantly higher abstinence from smoking compared with a placebo.

The researchers studied over 1500 adults over a period of six months who smoked at least 10 cigarettes a day. The patients were disqualified if they used any form of tobacco other than cigarettes, were currently taking the prescription medication buproprion, or had a mental health diagnosis of either psychosis or schizophrenia. All participants stated a motivation to quit smoking.

Bupropion is the generic name of the medication used as a smoking cessation drug (brand name Zyban) and as an antidepressant (Wellbutrin).

The participants were randomized to one of five treatment scenarios - nicotine lozenge alone, nicotine patch alone, sustained release buproprion alone or one of two combination therapies, buproprion plus lozenge or patch plus lozenge. The remainder of the study group received a placebo. All participants also received six individual smoking cessation counseling sessions with a case manager.

Smoking rates were assessed at one week, eight weeks, and six months after the beginning of the study.

All of the smoking cessation treatments worked better than the placebo for initial cessation and during the first week after quitting, but the therapy that provided the highest abstinence rate after six months was the patch plus lozenge combination, with a 40% success rate. The reasoning behind the successful combination is that the patch supplies a steady supply of nicotine replacement while the lozenge quells additional cravings.

In addition to initial cessation, participants who combined the patch and the lozenge were better able to remain smoke-free longer before having a cigarette or relapsing into regular smoking.

There were adverse events noted in each modality that was consistent with results from previous research: skin irritation associated with patch use, sleep disturbances and abnormal dreams for those on bupropion, and nausea for those on lozenges. Patients in the combination therapies reported more of the complications than those on single therapies or placebo. Four participants withdrew from the study, but there was only one serious event, hospitalization for seizures, which was possibly related to study medication, the researchers said.

The findings of this study complement the recommendation of the 2008 Update to the Public Health Service Treating Tobacco Use and Dependence Clinical Practice Guideline, which says that using the nicotine patch along with nicotine gum or spray is the most effective methods to quit smoking.



Archive issues: (50)

Archive list: 1 2 3 4 5 6 7 [8] 9 10 11 12 13 14 15 16 17

November 23, 2009 | Genetic Variant Slows AIDS Progression

Scientists report that a genetic variation appears to play a major role in slowing disease progression in HIV-infected patients.  In fact, those with the variation appear to take years longer to develop AIDS and die of complications of the disease.  "We're honing in on factors that vary across individuals that make a person more or less susceptible to HIV, in terms of how rapidly someone develops the disease," said study co-author Mary ...

November 22, 2009 | FDA To Reduce the Misuse of Medications

The FDA wants to reduce the misuse of medications, saying that at least 50,000 hospitalizations a year could be prevented if physicians, pharmacists, patients and parents would be more careful. And the cost of these preventable injuries is estimated at about $4 billion annually by the Institute of Medicine.  FDA commissioner Margaret A. Hamburg stated, "when ...

November 21, 2009 | Diabetes Drug Byetta Linked to Kidney Problems

The FDA has received 78 reports of kidney problems related to Byetta, a drug by Amylin Pharmaceuticals and Eli-Lilly prescribed to treat type 2 diabetes. With the new findings, the drug's label will be updated to warn doctors and patients about this possible side effect.  Byetta (exenatide) ...

Archive list: 1 2 3 4 5 6 7 [8] 9 10 11 12 13 14 15 16 17

Related articles:

Treatment - pelvic floor treatments

  Work by Wise and Anderson (see details) has shown that urologic pelvic pain syndromes, such as IC/PBS and CP/CPPS, may have no initial trigger other than anxiety, often with an element of Obsessive Compulsive Disorder or other anxiety-spectrum problem. This is theorized to leave the pelvic ...

Section: Interstitial cystitis

Chronic prostatitis/chronic pelvic pain syndrome - nomenclature

  The name of this disorder is evolving. In 2007, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) began using the umbrella term Urologic Chronic Pelvic Pain Syndromes (UCPPS), for research purposes, to refer to pain syndromes associated with the bladder (i.e. interstitial cystitis/painful bladder syndrome, IC/PBS) and the prostate gland (i.e. chronic prostatitis/chronic pelvic ...

Section: Prostatitis

Chronic bacterial prostatitis - treatment

  Treatment requires prolonged courses (4-8 weeks) of antibiotics that penetrate the prostate well (?-lactams and nitrofurantoin are ineffective). These include quinolones (ciprofloxacin, levofloxacin), sulfas (Bactrim, Septra) and macrolides (erythromycin, clarithromycin). Persistent infections may be helped in 80% of patients by the use of alpha ...

Section: Prostatitis

News

December 20, 2009

Wii, Xbox 360 and Other Video Games Offer Some Benefits

Wii, Xbox 360, PlayStation, and other video games are hot on holiday gift lists, but some parents wonder whether these games offer any benefits or are detrimental to kids. The results of a new study may put some minds at ease, while others may not.  According to the findings reported in the latest issue of Current ...

December 18, 2009

Should You Be Shoveling Snow?

Yes, the weather outside is frightful, and soon you will have to think about shoveling snow. But should you be the one doing the work? Who should and should not shovel snow, and how can you do it safely?  Every winter, approximately ...

December 17, 2009

Athletes who take NSAID's to prevent pain may be doing more harm than good

According to Stuart Warden, a researcher who studies musculoskeletal health and sports medicine, athletes who ritualistically take NSAID's to prevent post event and workout soreness and inflammation ...

Blogroll